Clorox expects the GOJO acquisition to add about 9.5 percentage points to fiscal 2027 net sales growth and be accretive to adjusted earnings per share. The company forecasts total net sales to increase 13-14%, with adjusted earnings projected at $5.70-$6.00 per share, up 3-8%. However, fiscal 2026 gross margin declined 290 basis points to 42.3%, and fiscal 2027 gross margin is expected to be about 42% amid inflation exceeding $200 million. Organic sales are forecast to rise 3.5-4.5%, but more than 3.5 points reflect an ERP comparison, leaving underlying organic sales flat to up slightly.
The Clorox CompanyCompany forecasts 13-14% sales growth and EPS accretion from GOJO deal.
Church & Dwight Company Inc
Procter & Gamble CompanyAcquisition by Clorox expected to add 9.5 points to sales growth and be accretive.
